New hope in the fight against cancer: What diseases does Venetoclax/Venetoclax tablets treat?

Venetoclax (Venetoclax) is an antineoplastic drug (cancer drug) that interferes with the growth of cancer cells, which are eventually destroyed by the body. This medicine is only available with a doctor's prescription. Patients can use venetoclax to treat the following conditions:

1. Chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL): Venetoclax can be used alone or together with other drugs (such as rituximab) to treat CLL or SLL in patients who have received at least one previous treatment, regardless of the presence of 17p deletion. It is also used with obinutuzumab to treat previously untreated CLL or SLL.

2. Acute myeloid leukemia (AML): Venetoclax can be used in combination with other drugs to treat newly diagnosed acute myeloid leukemia in adults aged 75 or above, or patients with comorbidities that preclude the use of intensive induction chemotherapy, such as azacitidine, decitabine or low-dose Cytarabine.

The original drug of Venekra has been launched in China and has been included in Class B medical insurance. The price of 100mg*14 tablets per box may be around 2,000 RMB, while the Turkish version of the original drug sold overseas, with the specification of 100mg*112 tablets, costs more than 10,000 RMB per box (the price may fluctuate due to the exchange rate). There are also cheaper generic drugs of Venacla sold overseas. Their pharmaceutical ingredients are basically the same as those of the original drugs sold domestically and abroad. For example, the price of 100mg*120 tablets produced by a Bangladesh pharmaceutical factory is more than 4,000 yuan per box (the price may fluctuate due to the exchange rate).